200
Views
0
CrossRef citations to date
0
Altmetric
Review

Small bowel transplant – novel indications and recent progress

, , , , &
Pages 677-690 | Received 12 Dec 2022, Accepted 24 May 2023, Published online: 05 Jun 2023

References

  • Kappus M, Diamond S, Hurt RT, et al. Intestinal failure: new definition and clinical implications. Curr Gastroenterol Rep. 2016;18(9):48. DOI:10.1007/s11894-016-0525-x
  • Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey. Clin Nutr. 2018;37(2):728–738. DOI:10.1016/j.clnu.2017.04.013
  • Buchman AL. Intestinal failure and rehabilitation. Gastroenterol Clin North Am. 2018;47(2):327–340. DOI:10.1016/j.gtc.2018.01.006
  • Duggan CP, Jaksic T, Ingelfinger JR. Pediatric intestinal failure. N Engl J Med. 2017;377(7):666–675.
  • Guillen B, Atherton NS. Short Bowel Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing LLC; 2022:1. JanJul 18.
  • Zorzetti N, D’Andrea V, Lauro A. Proteomic biomarkers in short bowel syndrome: are we ready to use them in clinical activity? Expert Rev Proteomics. 2021;18(4):285–293.
  • Fjermestad H, Hvistendahl M, Jeppesen PB. Fasting and postprandial plasma citrulline and the correlation to intestinal function evaluated by 72-hour metabolic balance studies in short bowel jejunostomy patients with intestinal failure. JPEN J Parenter Enteral Nutr. 2018;42:418–426.
  • Lauro A, Lacaille F. Short bowel syndrome in children and adults: from rehabilitation to transplantation. Expert Rev Gastroenterol Hepatol. 2019;13(1):55–70.
  • McKee RF, Knight K, Leitch EF, et al. Changes in adult home parenteral nutrition practice over 25 years. Clin Nutr ESPEN. 2021;45:170–176.
  • Barco S, Heuschen CB, Salman B, et al. Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals. J Thromb Haemost. 2016;14(7):1364–1373. DOI:10.1111/jth.13351
  • Gonzalez-Hernandez J, Daoud Y, Styers J, et al. Central venous thrombosis in children with intestinal failure on long-term parenteral nutrition. J Pediatr Surg. 2016;51(5):790–793. DOI:10.1016/j.jpedsurg.2016.02.024
  • Fonseca G, Burgermaster M, Larson E, et al. The relationship between parenteral nutrition and central line-associated bloodstream infections: 2009-2014. JPEN J Parenter Enteral Nutr. 2018;42(1):171–175. DOI:10.1177/0148607116688437
  • Gompelman M, Causevic E, Bleeker-Rovers CP, et al. Catheter-related bloodstream infection management in patients receiving home parenteral nutrition: an observational cohort study. Clin Nutr ESPEN. 2022;50:155–161.
  • Fuglsang KA, Brandt CF, Jeppesen PB. Survival in patients initiating home parenteral support due to nonmalignant short bowel syndrome compared with background population. Clin Nutr ESPEN. 2022;50:170–177.
  • Lezo A, D’Eusebio C, Riboldi L, et al. HPN standard of care and long-term outcomes of CIF pediatric patients: twenty-eight years’ experience in a reference center. Front Nutr. 2022;9:868273.
  • Cloutier A, Bond A, Taylor MI, et al. Successful implementation of remote video consultations for patients receiving home parenteral nutrition in a national UK Centre. Frontline Gastroenterol. 2019;11(4):280–284. DOI:10.1136/flgastro-2019-101257
  • Raphael BP, Schumann C, Garrity-Gentille S, et al. Virtual telemedicine visits in pediatric home parenteral nutrition patients: a quality improvement initiative. Telemed J E Health. 2019;25(1):60–65. DOI:10.1089/tmj.2017.0298
  • Bering J, DiBaise JK. Home parenteral and enteral nutrition. Nutrients. 2022;14(13):2558.
  • Adams SC, Gura KM, Seres DS, et al. Safe care transitions for patients receiving parenteral nutrition. Nutr Clin Pract. 2022;37(3):493–508. DOI:10.1002/ncp.10861
  • Choi YH, Kim MS, Kim CH, et al. Looking into the life of technology-dependent children and their caregivers in Korea: lifting the burden of too many responsibilities. BMC Pediatr. 2020;20(1):486. DOI:10.1186/s12887-020-02388-z
  • Lauro A, Coletta R, Morabito A. Restoring gut physiology in short bowel patients: from bench to clinical application of autologous intestinal reconstructive procedures. Expert Rev Gastroenterol Hepatol. 2019;13(8):785–796.
  • Pironi L. Definitions of intestinal failure and the short bowel syndrome. Best Pract Res Clin Gastroenterol. 2016;30(2):173–185. DOI:10.1016/j.bpg.2016.02.011
  • Fung JJ. William Hunter harridge lecture: the changing face of short-gut syndrome management. Am J Surg. 2017;213(3):448–451.
  • Kong W, Wang J, Ying R, et al. A potential anatomic subtype of short bowel syndrome: a matched case-control study. BMC Gastroenterol. 2016;16:12.
  • Lauro A, Cirocchi R, Cautero N, et al. Reconnection surgery in adult post-operative short bowel syndrome < 100 cm: is colonic continuity sufficient to achieve enteral autonomy without autologous gastrointestinal reconstruction? Report from a single center and systematic review of literature. G Chir. 2017;38(4):163–175. DOI:10.11138/gchir/2017.38.4.163
  • Sjoberg Bexelius T, Ahle M, Elfvin A, et al. Intestinal failure after necrotising enterocolitis: incidence and risk factors in a Swedish population-based longitudinal study. BMJ Paediatr Open. 2018;2(1):000316. DOI:10.1136/bmjpo-2018-000316
  • Pederiva F, Sgrò A, Coletta R, et al. Outcomes in patients with short bowel syndrome after autologous intestinal reconstruction: does etiology matter? J Pediatr Surg. 2018;53(7):1345–1350. DOI:10.1016/j.jpedsurg.2018.03.009
  • Zhu C, Li Y. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults. J Int Med Res. 2022;50(3):3000605221086145.
  • Suzuki R, Brown GA, Christopher JA, et al. Recent developments in therapeutic peptides for the glucagon-like peptide 1 and 2 receptors. J Med Chem. 2020;63(3):905–927. DOI:10.1021/acs.jmedchem.9b00835
  • Sun W, Chen LN, Zhou Q, et al. A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor. Cell Res. 2020;30(12):1098–1108. DOI:10.1038/s41422-020-00442-0
  • Norona J, Apostolova P, Schmidt D, et al. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans. Blood. 2020;136(12):1442–1455. DOI:10.1182/blood.2020005957
  • Gattex FDA approval history. Available from: http://www.drugs.com/history/gattex.html.04/03/2023
  • Gigola F, Cianci MC, Cirocchi R, et al. Use of Teduglutide in Children with Intestinal Failure: a Systematic Review. Front Nutr. 2022 Jun 14;9:866518. DOI:10.3389/fnut.2022.866518
  • Coletta R, Morabito A, Iyer K. Nontransplant surgery for intestinal failure. Gastroenterol Clin North Am. 2019;48(4):565–574.
  • Mundi MS, Mohamed Elfadil O, Hurt RT, et al. Management of long-term home parenteral nutrition: historical perspective, common complications, and patient education and training. JPEN J Parenter Enteral Nutr. 2023;47(1):S24–S34. DOI:10.1002/jpen.2424
  • van den Bosch CH, Jeremiasse B, van der Bruggen JT, et al. The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis. J Hosp Infect. 2021;123:143–155.
  • Mundi MS, Martindale RG, Hurt RT. Emergence of mixed-oil fat emulsions for use in parenteral nutrition. JPEN J Parenter Enter Nutr. 2017;41:3S–13S.
  • Chen YC, Chou CM, Huang SY, et al. Home parenteral nutrition for children: what are the factors indicating dependence and mortality? Nutrients. 2023;15(3):706. DOI:10.3390/nu15030706
  • Boroni G, Parolini F, Stern MV, et al. Autologous intestinal reconstruction surgery in short bowel syndrome: which, When, and Why. Front Nutr. 2022;9:861093.
  • Grainger JT, Maeda Y, Donnelly SC, et al. Assessment and management of patients with intestinal failure: a multidisciplinary approach. Clin Exp Gastroenterol. 2018;11:233–241.
  • Carey S, Kalachov M, Jones L, et al. Intestinal Failure Alliance of Australia. Development of consensus on models of care in adults with intestinal failure using a modified Delphi approach. J Gastroenterol Hepatol. 33(9). Epub ahead of print. 1598–1602. 2018 Feb 27. 10.1111/jgh.14132.
  • Neelis E, de Koning B, van Winckel M, et al. Wide variation in organization and clinical practice of pediatric intestinal failure teams: an international survey. Clin Nutr. 2018;37:2271–2279.
  • Javid PJ, Wendel D, Horslen SP. Organization and outcomes of multidisciplinary intestinal failure teams. Semin Pediatr Surg. 2018;27(4):218–222.
  • Merras-Salmio L, Mutanen A, Ylinen E, et al. Pediatric intestinal failure: the key outcomes for the first 100 patients treated in a National Tertiary Referral Center during 1984–2017. JPEN J Parenter Enteral Nutr. 2018;42:1304–1313.
  • Abu-Elmagd KM, Armanyous SR, Fujiki M, et al. Management of five hundred patients with gut failure at a single center: surgical innovation versus transplantation with a novel predictive model. Ann Surg. 2019;270(4):656–674. DOI:10.1097/SLA.0000000000003523
  • Fernandes MA, Usatin D, Allen IE, et al. Improved enteral tolerance following step procedure: systematic literature review and meta-analysis. Pediatr Surg Int. 2016;32(10):921–926. DOI:10.1007/s00383-016-3927-9
  • International Step Data Registry (Boston Children’s Hospital at. https://apps.childrenshospital.org/externalClinical/STEP/07/03/2023
  • Lauro A, Santoro A, Cirocchi R, et al. Serial transverse enteroplasty (STEP) in case of short bowel syndrome: did we achieve our goal? A systematic review. Updates Surg. 2022;74(4):1209–1223. DOI:10.1007/s13304-022-01316-3
  • Wester T, Lilja HE, Stenström P, et al. Absent ileocecal valve predicts the need for repeated step in children. Surgery. 2017;161(3):818–822. DOI:10.1016/j.surg.2016.09.011
  • Barrett M, Demehri FR, Ives GC, et al. Taking a STEP back: assessing the outcomes of multiple STEP procedures. J Pediatr Surg. 2017;52(1):69–73. DOI:10.1016/j.jpedsurg.2016.10.024
  • Coletta R, Aldeiri B, Morabito A. Institutional experience with spiral intestinal lengthening and tailoring. Eur J Pediatr Surg. 2019;29(5):412–416. DOI:10.1055/s-0038-1660850
  • Ripoli MC, Lauro A. Letter to the Editor on: “Gastrointestinal tract reconstruction in adults with ultra-short-bowel syndrome: surgical and nutritional outcomes”. Surgery. 2021;170(2):646.
  • van Praagh JB, Hofker HS, Haveman JW, et al. Comparing bowel lengthening procedures: which, when, and why? Curr Opin Organ Transplant. 2022;27(2):112–118.
  • Pironi L, Sasdelli AS. New insights into the indications for intestinal transplantation. Curr Opin Organ Transplant. 2021;26:186–191.
  • Kaufman SS, Avitzur Y, Beath SV, et al. New Insights into the Indications for Intestinal Transplantation: consensus in the Year 2019. Transplantation. 2020;104(5):937–946. DOI:10.1097/TP.0000000000003065
  • Centers for Medicare & Medicaid Services - Intestinal and Multi-Visceral Transplantation. https://www.cms.gov/medicare-coverage-database/view. jul 3 2023
  • Kahn AB, Tulla KA, Tzvetanov IG. Indications of Intestinal Transplantation. Gastroenterol Clin North Am. 2019;48(4):575–583.
  • Roberts AJ, Wales PW, Beath SV, et al. An international multicentre validation study of the Toronto listing criteria for pediatric intestinal transplantion. Am J Transplant. 2022 Nov;22:2608–2615.
  • Smith JM, Weaver T, Skeans MA, et al. OPTN/SRTR 2018 Annual Data Report: intestine. Am J Transplant. 2020;20:300–339.
  • Pironi L, Arends J, Bozzetti F, et al.; Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247–307. DOI:10.1016/j.clnu.2016.01.020
  • Horslen SP, Smith JM, Weaver T, et al. OPTN/SRTR 2020 Annual Data Report: intestine. Am J Transplant. 2022;22:310–349.
  • Lauro A, Marino IR, Iyer KR. Pre-emptive intestinal transplant: the surgeon’s point of view. Dig Dis Sci. 2017;62(11):2966–2976. DOI:10.1007/s10620-017-4752-2
  • Talayero P, Ramos Boluda E, Gómez Massa E, et al. Donor-specific antibodies in pediatric intestinal and multivisceral transplantation: the role of liver and human leukocyte antigen mismatching. Liver Transpl. 2018;24(12):1726–1735. DOI:10.1002/lt.25323
  • Fernández J, Bert F, Nicolas-Chanoine MH. The challenges of multi-drug-resistance in hepatology. J Hepatol. 2016;65(5):1043–1054.
  • Smith JM, Weaver T, Skeans MA, et al. OPTN/SRTR 2017 Annual Data Report: intestine. Am J Transplant. 2019;19:284–322.
  • Bharadwaj S, Tandon P, Gohel TD, et al. Current status of intestinal and multivisceral transplantation. Gastroenterol Rep. 2017;5:20–28.
  • Kesseli S, Sudan D. Small Bowel Transplantation. Surg Clin North Am. 2019;99(1):103–116.
  • Matsumoto CS, Subramanian S, Fishbein TM. Adult intestinal transplantation. Gastroenterol Clin North Am. 2018;47(2):341–354.
  • Farinelli PA, Rubio JS, Padín JM, et al. Use of nonvascularized abdominal rectus fascia after liver, small bowel, and multiorgan transplantation: long-term follow-up of a single-center series. Transplant Proc. 2017;49(8):1810–1814. DOI:10.1016/j.transproceed.2017.05.012
  • Jo SC, McCallum Z, Shalley H, et al. Outcomes of children with chronic intestinal failure: experience over 2 decades at a tertiary pediatric hospital. J Pediatr Gastroenterol Nutr. 2019;69:79–87.
  • Norsa L, Artru S, Lambe C, et al. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: parenteral nutrition or intestinal transplantation. Clin Nutr. 2019;38(2):926–933. DOI:10.1016/j.clnu.2018.02.004
  • Sudan DL, Iyer KR, Deroover A, et al. A new technique for combined liver/small intestinal transplantation. Transplantation. 2001;72(11):1846–1848. DOI:10.1097/00007890-200112150-00025
  • Fishbein T, Florman S, Gondolesi G, et al. Noncomposite simultaneous liver and intestinal transplantation. Transplantation. 2003;75(4):564–565. DOI:10.1097/01.TP.0000045711.68765.84
  • Hukkinen M, Kivisaari R, Lohi J, et al. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure. Liver Int. 2016;36(3):361–369. DOI:10.1111/liv.12887
  • Beath SV, Davies P, Mukherjee A, et al. A comparison of two validated scores for estimating risk of mortality of children with intestinal failure associated liver disease and those with liver disease awaiting transplantation. Clin Res Hepatol Gastroenterol. 2014;38(1):32–39. DOI:10.1016/j.clinre.2013.06.001
  • Van Gossum A, Pironi L, Messing B, et al. Transient elastography (fibroscan) is not correlated with liver fibrosis but with cholestasis in patients with long-term home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2015;39(6):719–724. DOI:10.1177/0148607114538057
  • Kato T, Nishida S, Levi D, et al. Multivisceral transplantation without the liver. Transplant Proc. 2002;34(3):910. DOI:10.1016/S0041-1345(02)02664-7
  • Vianna R, Beduschi T. Multivisceral transplantation for diffuse splanchnic venous thrombosis. Curr Opin Organ Transplant. 2016;21(2):201–208.
  • Nikeghbalian S, Aliakbarian M, Shamsaeefar A, et al. Multivisceral transplantation for the treatment of intra-abdominal tumors. Transplant Proc. 2013;45(10):3528–3530. DOI:10.1016/j.transproceed.2013.09.002
  • Matsumoto C, Kaufman S, Fishbein T. Inclusion of the colon in intestinal transplantation. Curr Opin Organ Transplant. 2011;16(3):312–315.
  • Moon JI, Zhang H, Waldron L, et al. “Stoma or no stoma”: first report of intestinal transplantation without stoma. Am J Transplant. 2020;20(12):3550–3557. DOI:10.1111/ajt.16065
  • Hakim B, Myers DT, Williams TR, et al. Intestinal transplants: review of normal imaging appearance and complications. Br J Radiol Suppl. 2018;91(1090):20180173. DOI:10.1259/bjr.20180173
  • Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal Transplant Association. Intestinal transplant registry report: global activity and trends. Am J Transplant. 2015;15(1):210–219. DOI:10.1111/ajt.12979
  • Gondolesi GE. Induction in intestinal transplantation. Transplantation. 2020;104(10):1999–2000.
  • Elsabbagh AM, Hawksworth J, Khan KM, et al. Long-term survival in visceral transplant recipients in the new era: a single-center experience. Am J Transplant. 2019;19(7):2077–2091. DOI:10.1111/ajt.15269
  • Ceulemans LJ, Braza F, Monbaliu D, et al. The Leuven immunomodulatory protocol promotes T-regulatory cells and substantially prolongs survival after first intestinal transplantation. Am J Transplant. 2016;16(10):2973–2985. DOI:10.1111/ajt.13815
  • Issa F, Strober S, Leventhal JR, et al. The fourth international workshop on clinical transplant tolerance. Am J Transplant. 2021;21(1):21–31. DOI:10.1111/ajt.16139
  • Fu J, Zuber J, Shonts B, et al. Lymphohematopoietic graft-versus-host responses promote mixed chimerism in patients receiving intestinal transplantation. J Clin Invest. 2021;131(8):141698. DOI:10.1172/JCI141698
  • Merola J, Shamim A, Weiner J. Update on immunosuppressive strategies in intestinal transplantation. Curr Opin Organ Transplant. 2022;27(2):119–125.
  • Santeusanio AD, Gu A, Weinberg AD, et al. Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation. Clin Transplant. 2021;35(6):14291. DOI:10.1111/ctr.14291
  • Andres AM, Talayero P, Alcolea Sanchez A, et al. Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long term benefits. Transplant Int. 2021;34:1895–1907.
  • Nishida S, Levi DM, Moon JI, et al. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients. Transplant Proc. 2006;38(6):1747–1749. DOI:10.1016/j.transproceed.2006.05.057
  • Reyes J, Mazariegos GV, Abu-Elmagd K, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant. 2005;5:1430–1436.
  • Vianna RM, Mangus RS, Fridell JA, et al. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation. 2008;85(9):1290–1293. DOI:10.1097/TP.0b013e31816dd450
  • Beiras-Fernandez A, Chappell D, Hammer C, et al. Influence of polyclonal anti-thymocyte globulins upon ischemia–reperfusion injury in a non-human primate model. Transpl Immunol. 2006;15(4):273–279. DOI:10.1016/j.trim.2006.02.003
  • Bogetti D, Jarzembowski TM, Sankary HN, et al. Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Transplant Proc. 2005;37(1):404–406. DOI:10.1016/j.transproceed.2004.12.064
  • Vianna R, Farag A, Gaynor JJ, et al. Association of More Intensive Induction with Less Acute Rejection Following Intestinal Transplantation: results of 445 Consecutive Cases from a Single Center. Transplantation. 2020;104(10):2166–2178. DOI:10.1097/TP.0000000000003074
  • Abu-Elmagd KM, Wu G, Costa G, et al. Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant. 2012;12(11):3047–3060. DOI:10.1111/j.1600-6143.2012.04237.x
  • Cheng EY, Everly MJ, Kaneku H, et al. Prevalence and clinical impact of donor specific alloantibody among intestinal transplant recipients. Transplantation. 2017;101:873–882.
  • Gerlach UA, Lachmann N, Ranucci G, et al. Non-HLA antibodies may accelerate immune responses after intestinal and multivisceral transplantation. Transplantation. 2017;101(1):141–149. DOI:10.1097/TP.0000000000001439
  • Santeusanio AD, Moon J, Nair V, et al. Is There a Role for Desensitization in Intestinal Transplantation? Prog Transplant. 2019;29(3):275–278. DOI:10.1177/1526924819855088
  • Garcia-Roca R, Tzvetanov IG, Jeon H, et al. Successful living donor intestinal transplantation in cross-match positive recipients: initial experience. World J Gastrointest Surg. 2016;8:101–105.
  • Horslen SP, Smith JM, Ahn Y, et al. OPTN/SRTR 2019 annual data report: intestine. Am J Transplant. 2021;21:316–355.
  • Huard G, Schiano TD, Moon J, et al. Severe acute cellular rejection after intestinal transplantation is associated with poor patient and graft survival. Clin Transplant. 2017;31(5):12956. DOI:10.1111/ctr.12956
  • Devine K, Ranganathan S, Mazariegos G, et al. Induction regimens and posttransplantation lymphoproliferative disorder after pediatric intestinal transplantation: single-center experience. Pediatr Transplant. 2020;24:13723.
  • Wu GS, Zhao QC, Li ZS, et al. Successful rescue of late-onset antibody mediated rejection 12 years after living-donor intestinal transplantation: a case report. Transplant Proc. 2017;49:232–236.
  • Trentadue G, Kats-Ugurlu G, Blokzijl T, et al. Safe and successful treatment of acute cellular rejection of an intestine and abdominal wall transplant with vedolizumab. Transplant Direct. 2020;6:527.
  • Kroemer A, Belyayev L, Khan K, et al. Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab. Am J Transplant. 2021;21(3):1238–1254. DOI:10.1111/ajt.16283
  • Sano T, Kageyama T, Fang V, et al. Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes. Cell Rep. 2021;36(8):109608. DOI:10.1016/j.celrep.2021.109608
  • Fujiwara S, Wada M, Kudo H, et al. Effectiveness of bortezomib in a patient with acute rejection associated with an elevation of donor-specific HLA antibodies after small-bowel transplantation: case report. Transplant Proc. 2016;48:525–527.
  • Fan J, Tryphonopoulos P, Tekin A, et al. Eculizumab salvage therapy for antibody-mediated rejection in a desensitization-resistant intestinal re-transplant patient. Am J Transplant. 2015;15(7):1995–2000. DOI:10.1111/ajt.13183
  • Cristofori F, Dargenio VN, Dargenio C, et al. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12:578386.
  • Burrello C, Garavaglia F, Cribiù FM, et al. Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells. Nat Commun. 2018;9(1):5184. DOI:10.1038/s41467-018-07359-8
  • Issa NC, Fishman JA. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis. 2009;48(6):772–786.
  • Kubal CA, Pennington K, Fridell J, et al. Challenges with Intestine and Multivisceral Re-Transplantation: importance of Timing of Re-Transplantation and Optimal Immunosuppression. Ann Transplant. 2018;23:98–104.
  • Kroemer A, Khan K, Kaufman SS, et al. Operational tolerance in intestinal transplantation. Am J Transplant. 2021;21(2):876–882. DOI:10.1111/ajt.16224
  • Clouse JW, Kubal CA, Fridell JA, et al. One-year Incidence of Infection in Pediatric Intestine Transplantation. Pediatr Infect Dis J. 2019;38(3):219–223. DOI:10.1097/INF.0000000000002104
  • Fishbein TM. Intestinal transplantation. N Engl J Med. 2009;361(10):998–1008.
  • Oertel SH, Verschuuren E, Reinke P, et al. Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant. 2005;5:2901–2906.
  • Kaenkumchorn TK, Wendel D, Pacheco MC, et al. Late graft loss after intestinal transplantation. Curr Opin Organ Transplant. 2021;26(2):220–228. DOI:10.1097/MOT.0000000000000851
  • Ganoza A, Mazariegos GV, Khanna A. Current status of graft-versus-host disease after intestinal transplantation. Curr Opin Organ Transplant. 2019;24(2):199–206.
  • Kaufman SS, Hussan E, Kroemer A, et al. Graft versus Host Disease After Intestinal Transplantation: a Single-center Experience. Transplant Direct. 2021;7:731.
  • Vianna R, Farag A, Gaynor JJ, et al. Association of Alemtuzumab Induction with a Significantly Lower Incidence of GVHD Following Intestinal Transplantation: results of 445 Consecutive Cases from a Single Center. Transplantation. 2020;104(10):2179–2188. DOI:10.1097/TP.0000000000003111
  • Venick RS. Long-term results of intestinal transplantation in children: survival after 10 years, intestinal function, quality of life. Curr Opin Organ Transplant. 2018;23(2):219–223.
  • Gondolesi GE, Fernandez A, Burghardt KM, et al. Meeting report of the XIV international small bowel transplant symposium: summary of presentations, workshops, and debates from a comprehensive meeting on intestinal failure, rehabilitation, and transplantation, Buenos Aires, Argentina, June 10-13, 2015. JPEN J Parenter Enteral Nutr. 2018;42:477–489.
  • Garcia J, Selvaggi G, Tekin A, et al. Intestinal transplantation. Curr Opin Organ Transplant. 2021;26(2):229–233. DOI:10.1097/MOT.0000000000000865
  • Oltean M. Intestinal transplantation: an overview of the recent experimental studies. Curr Opin Organ Transplant. 2021;26(2):240–244.
  • Zou Z, Wang Z. Liraglutide attenuates intestinal ischemia/reperfusion injury via NF-κB and PI3K/Akt pathways in mice. Life Sci. 2022;309:121045.
  • Lauro A, Marino IR, Matsumoto CS. Advances in allograft monitoring after intestinal transplantation. Curr Opin Organ Transplant. 2016;21(2):165–170.
  • Carroll RE. Endoscopic follow-up of intestinal transplant recipient. Gastroentrol Clin North Am. 2018;47:381–391.
  • Varkey J, Stotzer PO, Simren M, et al. The endoscopic surveillance of the transplanted small intestine: a single center experience and a proposal for a grading score. Scand J Gastroenterol. 2018;53(2):134–139. DOI:10.1080/00365521.2017.1411523
  • Gerlach UA, Klöpfel M, Atanasov G, et al. Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. Transplantation. 2017;101(5):1036–1045. DOI:10.1097/TP.0000000000001469
  • Osman M, Parekh N, Fujiki M, et al. Disease Recurrence after Gut Transplantation. Curr Opin Organ Transplant. 2021;26(2):207–219. DOI:10.1097/MOT.0000000000000856
  • Hind J. Long-term outcomes of intestinal transplantation. Curr Opin Organ Transplant. 2021;26(2):192–199.
  • Oltean M, Hedenström P, Varkey J, et al. Endoscopic ultrasound in the monitoring of the intestinal allograft. BMJ Open Gastroenterol. 2022;9(1):e000792. DOI:10.1136/bmjgast-2021-000792
  • Pironi L, Guidetti M, Lauro A, et al. Plasma citrulline after small bowel transplantation: effect of time from transplantation, acute cellular rejection, and renal failure. Clin Transplant. 2015;29(11):1039–1046. DOI:10.1111/ctr.12630
  • Smullin CP, Venick RS, Marcus EA, et al. REG3α is a novel biomarker that potentially correlates with acute allograft rejection after intestinal transplantation. Clin Transplant. 2021;35(7):e14378. DOI:10.1111/ctr.14378
  • Guerra MR, Rossetti M, Zhang Z, et al. Characterization of T cell immunophenotypes in intestinal transplantation: a pilot study. Transpl Immunol. 2018;51:50–57.
  • Tran LC, Lazonby G, Morello R, et al. How good is quality-of-life for children receiving home parenteral nutrition? - a pilot study. Clin Nutr ESPEN. 2019;29:119–124.
  • Baxter JP, Fayers PM, Bozzetti F, et al. Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN). An international study of the quality of life of adult patients treated with home parenteral nutrition. Clin Nutr. 2019;38(4):1788–1796. DOI:10.1016/j.clnu.2018.07.024
  • Roskott AM, Groen H, Rings EH, et al. Cost-effectiveness of intestinal transplantation for adult patients with intestinal failure: a simulation study. Am J Clin Nutr. 2015;101(1):79–86. DOI:10.3945/ajcn.114.083303
  • Raghu VK, Rudolph JA, Smith KJ. Cost-effectiveness of teduglutide in pediatric patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria. Am J Clin Nutr. 2021;113(1):172–178.
  • Hussain S, Mehta A, Pettle T, et al. Multicenter Evaluation of Current Knowledge of Intestinal Transplantation and Rehabilitation Among Trainee Physicians. Transplant Proc. 2015;47(6):1988–1992. DOI:10.1016/j.transproceed.2015.04.099
  • Iyer K, Moon J. Adult intestinal transplantation in the United States. Curr Opin Organ Transplant. 2020;25(2):196–200.
  • Kaplan J, Han L, Halgrimson W, et al. The impact of MELD/PELD revisions on the mortality of liver-intestine transplantation candidates. Am J Transplant. 2011;11:1896–1904.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.